Pharmacodynamic Activity of JNJ-67484703 in Rheumatoid Arthritis, Ulcerative Colitis and Sjogren's syndrome (PARIS): A phase 2 proof of biology trial

Project Details

Short titlePharmacodynamic Activity of JNJ-67484703 in Rheumatoid Arthritis, Ulcerative Colitis and Sjogren's syndrome (PARIS): A phase 2 proof of biology trial
StatusActive
Effective start/end date1/02/22 → 30/06/24

Funding

  • Janssen Research & Development, LLC